UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): May 25, 2005
|
Chembio
Diagnostics, Inc. |
(Exact
name of registrant as specified in its charter)
|
Nevada |
333-85787 |
88-0425691 |
|
(State
or other jurisdiction
of
incorporation) |
(Commission
File Number) |
(IRS
Employer Identification No.) |
3661
Horseblock Road, Medford, NY 11763
(Address
of principal executive offices) (Zip
Code)
Registrant's
telephone number, including area code (631)
924-1135
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM
8.01. Other Events.
On May
25, 2005, the Registrant issued the press release included herein as Exhibit
99.1.
ITEM
9.01. Financial Statements and Exhibits
(c) Exhibits.
99.1 Press
Release issued May 25, 2005.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| |
|
|
| Date: May 25, 2005 |
CHEMBIO DIAGNOSTICS,
INC. |
|
|
|
|
By: |
/s/ Lawrence A.
Siebert |
| |
Lawrence A. Siebert |
| |
Chief Executive
Officer |